According to filings with the U.S. Securities and Exchange Commission, SleepRes is raising up to $6 Million in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About SleepRes
SleepRes is a respiratory MedTech company that is revolutionizing positive airway pressure (PAP) therapy so people living with sleep apnea can achieve more restful, restorative sleep. The company is dedicated to creating effective, comfort-focused pressure-delivery solutions that adapt to patients natural breathing instead of forcing them to struggle against constant airflow, challenging decades of status-quo, tolerance-based PAP therapies. Guided from the beginning by physician insight, including a founder who is a board-certified sleep physician, SleepRes has developed KPAP, a fundamentally new algorithmic approach to pressure delivery rooted in a deeper understanding of upper airway biology and the interaction between pressure and pharyngeal patency. SleepRess work is built on the belief that progress in PAP therapy must improve patient comfort as much as clinical effectiveness, and the company shows up every day to design, develop, and advance new approaches that deliver the right pressure at the right time and work with natural breathing patterns. By focusing on solutions that are as comfortable as they are effective, SleepRes aims to set a new standard of PAP therapy and create a world in which people with sleep apnea no longer have to struggle through their treatment.

To learn more, visit https://sleepres.com/
LinkedIn: https://www.linkedin.com/company/sleepres/

Contact:
Craig Salazar, Chief Financial Officer

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.